VCIG lowers warrant coverage to $13.3M; reduces total registered exposure by $47.1M
Rhea-AI Filing Summary
VCI Global amended its prospectus supplement to reduce the maximum value of ordinary shares that may be sold to Alumni Capital from $120,077,348 to $78,927,348 and to reduce the maximum value of Warrant Shares issuable under the Commitment Warrant from $19,250,000 to $13,300,000. The Offered Shares include Purchase Shares issuable under the Purchase Agreement and Warrant Shares issuable under the three-year Commitment Warrant.
The amendment therefore lowers the total registered exposure to Alumni Capital by $47,100,000 in aggregate (a $41,150,000 reduction in Purchase Shares plus a $5,950,000 reduction in Warrant Shares). The document reiterates that Alumni Capital is an underwriter and that registration does not obligate purchase or issuance. The company notes its Nasdaq symbol VCIG and a last reported sale price of $0.8960 per share.
Positive
- Maximum Purchase Share registration reduced by $41,150,000, lowering the ceiling on potential share issuance to Alumni Capital.
- Maximum Warrant Share registration reduced by $5,950,000, decreasing the potential warrant-related dilution.
- Total registered exposure lowered by $47,100,000, which reduces the upper bound of dilution if all registered securities were issued or exercised.
Negative
- Registration does not guarantee purchase or issuance; the company may not receive the full amount of proceeds implied by the registered amounts.
- Investing involves a high degree of risk as noted in the prospectus; material risks remain and could affect shareholder value.
Insights
TL;DR: Amendment materially reduces the maximum registered issuance and warrant exposure, lowering potential dilution by $47.1M.
The prospectus supplement narrows the company’s maximum registered issuance to Alumni Capital, decreasing Purchase Shares from $120.08M to $78.93M and Warrant exposure from $19.25M to $13.3M. This reduces the aggregate registered capital issuance by $47.1M, which, if exercised, would have represented direct dilution pressure. The filing also reiterates that registration does not guarantee sales, so actual dilution depends on future transactions under the Purchase Agreement and warrant exercise mechanics.
TL;DR: This is a disclosure-driven amendment reflecting a narrower registration; it preserves standard underwriter and registration disclaimers.
The amendment updates the range of securities registered for resale to align with changes to the Purchase Agreement and Commitment Warrant. The filing explicitly states Alumni Capital’s status as an underwriter and repeats that registration is not an indication of actual purchases. From a governance and disclosure perspective, the company has documented the contractual scope and limited the maximum registered amounts, which is routine but material to shareholder dilution considerations.
Filed Pursuant to Rule 424(b)(5)
Registration Statement No. 333-279521
Prospectus Supplement
(To Prospectus dated May 28, 2024)
Up to $92,327,348
Ordinary Shares
This prospectus supplement amends and supplements the prospectus supplement dated January 22, 2025, which amended and supplemented the prospectus supplement dated December 17, 2024 and accompanying prospectus dated May 28, 2024 (collectively the “ELOC Prospectus”) relating to (i) the issuance and sale of our ordinary shares, no par value per share (the “Purchase Shares”), to Alumni Capital LP (“Alumni Capital”) upon the satisfaction of certain conditions set forth in the Purchase Agreement (the “Purchase Agreement”) dated August 1, 2024, between us and Alumni Capital and amended by a Modification Agreement dated as of September 27, 2024, the Amended Modification Agreement dated as of January 13, 2025, the Amended Modification Agreement dated May 21, 2025, at a purchase price per share calculated under the Purchase Agreement and (ii) a three-year ordinary share purchase warrant issued on August 1, 2024 (the “Commitment Warrant”) to purchase ordinary shares (the “Warrant Shares” and together with the Purchase Shares, the “Offered Shares”) pursuant to the Commitment Warrant at an exercise price determined by a formula that is described under “Alumni Capital Transaction.”
We are filing the Prospectus Supplement to amend the ELOC Prospectus to decrease (i) the maximum amount of our ordinary shares that may be sold to Alumni Capital under the ELOC Prospectus and Purchase Agreement from $120,077,348 to $78,927,348; (ii) the maximum amount of Warrant Share that may be issued and sold to Alumni Capital under the ELOC Prospectus and Commitment Warrant from $19,250,000 to $13,300,000.
Alumni Capital is an underwriter within the meaning of Section 2(a)(11) of the U.S. Securities Act of 1933, as amended (the “Securities Act”). The registration of the Offered Shares hereunder does not mean that Alumni Capital will actually purchase or that the Company will actually issue and sell all or any of the Offered Shares being registered pursuant to the registration statement related to this prospectus supplement.
You should read this prospectus supplement, the base prospectus, and any additional prospectus supplement or amendment carefully before you invest in our securities.
Our ordinary shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbols “VCIG.” On August 12, 2025, the last reported sale price of our ordinary shares on Nasdaq was $0.8960 per share.
Investing in our securities involves a high degree of risk. See “Risk Factors” section beginning on page S-6.
We are an “emerging growth company,” as that term is defined under the federal securities laws and, as such, we have elected to comply with certain reduced public company reporting requirements and may elect to do so in future filings.
Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.
The date of this prospectus supplement is August 13, 2025.